World's Best Scientists 2026 revealed!
Richard L. Schilsky

Richard L. Schilsky

D-Index & Metrics

Medicine

D-Index
102
Citations
64988
World Ranking
7492
National Ranking
3916

Overview

Richard L. Schilsky is affiliated with the University of Chicago in the United States and specializes in medicine, with a significant focus on oncology. Their research contributions span various subfields, including oncology, pulmonary and respiratory medicine, cancer research, economics and econometrics, and molecular biology.

Their primary areas of study include cancer genomics and diagnostics, lung cancer treatments and mutations, colorectal cancer treatments and studies, pancreatic and hepatic oncology research, advanced breast cancer therapies, cancer immunotherapy and biomarkers, and the economic and financial impacts of cancer.

Schilsky has published extensively, with frequent appearances in several prominent publication venues such as:

  • Journal of Clinical Oncology
  • JCO Precision Oncology
  • Cancer Research
  • JCO Oncology Practice
  • UNC Libraries

Recent papers authored or co-authored by Schilsky include:

  • "Closing the Rural Cancer Care Gap: Three Institutional Approaches," 2020, JCO Oncology Practice
  • "Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey," 2020, JCO Oncology Practice
  • "Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study," 2021, Journal of Clinical Oncology
  • "Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology," 2020, Journal of Clinical Oncology
  • "Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement," 2021, Clinical Cancer Research

Frequent collaborators include the following co-authors:

  • Elizabeth Garrett-Mayer
  • Pam K. Mangat
  • Susan Halabi
  • Gina N. Grantham
  • Eugene R. Ahn

Schilsky's scholarly output reflects a multidisciplinary approach to cancer research, integrating clinical oncology with economic and molecular perspectives. Their involvement in studies addressing clinical trial design and cancer care accessibility indicates an engagement with both practical and policy-related dimensions of oncology.

Best Publications

  • AJCC Cancer Staging Manual

    Mahul B. Amin;Stephen B. Edge;Frederick L. Greene;David R. Byrd

  • Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

    Marc L. Citron;Donald A. Berry;Constance Cirrincione;Clifford Hudis

  • Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

    I. Craig Henderson;Donald A. Berry;George D. Demetri;Constance T. Cirrincione

  • American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy

    Carmen J. Allegra;Carmen J. Allegra;J. Milburn Jessup;Mark R. Somerfield;Stanley R. Hamilton

  • Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

    Jason D. Merker;Geoffrey R. Oxnard;Carolyn Compton;Maximilian Diehn

  • A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

    Robert S. Sandler;Susan Halabi;John A. Baron;Susan Budinger

  • Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

    Gary M. Strauss;James E. Herndon;Michael A. Maddaus;David W. Johnstone

  • Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

    Hedy Lee Kindler;Donna Niedzwiecki;Donna Hollis;Susan Sutherland

  • American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

    Lowell E. Schnipper;Nancy E. Davidson;Dana S. Wollins;Courtney Tyne

  • Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803

    Jeffrey A. Meyerhardt;Denise Heseltine;Donna Niedzwiecki;Donna Hollis

  • Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

    Alan P. Venook;Donna Niedzwiecki;Heinz Josef Lenz;Federico Innocenti

  • UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

    L Iyer;S Das;L Janisch;M Wen

  • Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

    Gary J. Kelloff;John M. Hoffman;Bruce Johnson;Howard I. Scher

  • Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

    Lowell E. Schnipper;Nancy E. Davidson;Dana S. Wollins;Douglas W. Blayney

  • First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin

    J. Cassidy;C. Twelves;E. Van Cutsem;P. Hoff

  • Recommendations for management of patients with neuroendocrine liver metastases

    Andrea Frilling;Irvin M. Modlin;Mark Kidd;Christopher Russell

  • Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633

    G. M. Strauss;J. Herndon;M. A. Maddaus;D. W. Johnstone

  • Diagnosis, Management, and Evaluation of Chemotherapy-Induced Peripheral Neuropathy

    Frederick H. Hausheer;Richard L. Schilsky;Stacey Bain;Elmer J. Berghorn

  • A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

    Robert S. Sandler;Susan Halabi;John A. Baron;Susan Budinger

  • Cetuximab in the treatment of colorectal cancer.

    Richard M Goldberg;Alan P Venook;Richard L Schilsky

Frequent Co-Authors

Mark J. Ratain
Mark J. Ratain University of Chicago
Donna Niedzwiecki
Donna Niedzwiecki Duke University
Everett E. Vokes
Everett E. Vokes University of Chicago
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Alan P. Venook
Alan P. Venook University of California, San Francisco
Robert J. Mayer
Robert J. Mayer Dana-Farber Cancer Institute
Susan Halabi
Susan Halabi Duke University
Richard M. Goldberg
Richard M. Goldberg West Virginia University
Federico Innocenti
Federico Innocenti University of North Carolina at Chapel Hill
Razelle Kurzrock
Razelle Kurzrock Medical College of Wisconsin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA opens many doors beyond the traditional MD pathway. For those interested in patient care, online nurse practitioner programs provide the flexibility to advance your education and clinical skills while working. These programs are ideal for registered nurses seeking greater autonomy and specialized roles.

Cost is a major factor for many students. Thankfully, the cheapest online MSN programs make advanced nursing degrees more accessible. These affordable options allow nurses to pursue leadership, teaching, or advanced practice roles without incurring overwhelming debt.

For those aiming for academic or research-oriented careers, a phd in nursing unlocks opportunities in university teaching, research, and specialized clinical practice. Online formats make it possible to balance these rigorous programs with work and family life.

If you are a registered nurse looking to boost your credentials and earning potential, consider the cheapest rn to bsn online programs. Completing a BSN can lead to better job opportunities, higher salaries, and a solid foundation for further study in the medical field.

Best Scientists Citing Richard L. Schilsky

Trending Scientists

Recently Published Articles